Paper2146239
Kinetic analysis of 5-fluorouracil action against various cancer cells.
Inaba M and 2 others. Jpn J Cancer Res, 1990. Cited by 40 papers, by iCite.
Cite this record
ConductScience Library. Kinetic analysis of 5-fluorouracil action against various cancer cells. Papers, record 2146239. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2146239
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cell Cycle | Major topic |
| Fluorouracil | Major topic |
| Animals | |
| Antineoplastic Agents | |
| Colonic Neoplasms | |
| Dose-Response Relationship, Drug | |
| Floxuridine | |
| Humans | |
| Kidney Neoplasms | |
| Leukemia P388 | |
| Mice | |
| RNA, Ribosomal | |
| S Phase | |
| Time Factors | |
| Uridine |
Source PubMed
References28
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 3129204 | Cell killing action of cell cycle phase-non-specific antitumor agents is dependent on concentration--time product. | Cancer Chemother Pharmacol | 1988 | https://conductscience.org/library/papers/3129204 | PubMed |
| 2 | 3732354 | Binding of 5-fluorodeoxyuridylate to thymidylate synthase in human colon adenocarcinoma xenografts. | Eur J Cancer Clin Oncol | 1986 | https://conductscience.org/library/papers/3732354 | PubMed |
| 3 | 6766799 | Treatment of cultured human colon carcinoma cells with fluorinated pyrimidines. | Cancer | 1980 | https://conductscience.org/library/papers/6766799 | PubMed |
| 4 | 3008760 | Relationship between 5-fluoro-2'-deoxyuridylate, 2'-deoxyuridylate, and thymidylate synthase activity subsequent to 5-fluorouracil administration, in xenografts of human colon adenocarcinomas. | Biochem Pharmacol | 1986 | https://conductscience.org/library/papers/3008760 | PubMed |
| 5 | 2578606 | Cytotoxicity and the inhibition of ribosomal RNA processing in human colon carcinoma cells. | Mol Pharmacol | 1985 | https://conductscience.org/library/papers/2578606 | PubMed |
| 6 | 4258018 | Cell cycle phase specificity of antitumor agents. | Cancer Res | 1972 | https://conductscience.org/library/papers/4258018 | PubMed |
| 7 | 2736524 | Kinetic analysis of cell killing effect induced by cytosine arabinoside and cisplatin in relation to cell cycle phase specificity in human colon cancer and Chinese hamster cells. | Cancer Res | 1989 | https://conductscience.org/library/papers/2736524 | PubMed |
| 8 | 6688119 | Relationship of cellular folate cofactor pools to the activity of 5-fluorouracil. | Mol Pharmacol | 1983 | https://conductscience.org/library/papers/6688119 | PubMed |
| 9 | 6444543 | On the mechanism of cytotoxicity of fluorinated pyrimidines in four human colon adenocarcinoma xenografts maintained in immune-deprived mice. | Cancer | 1980 | https://conductscience.org/library/papers/6444543 | PubMed |
| 10 | 3698176 | The inhibitory effects of 5-fluorouracil on the metabolism of preribosomal and ribosomal RNA in L-1210 cells in vitro. | Cancer Chemother Pharmacol | 1986 | https://conductscience.org/library/papers/3698176 | PubMed |
| 11 | 2971656 | Mechanism of the cytotoxic synergism of fluoropyrimidines and folinic acid in mouse leukemic cells. | J Biol Chem | 1988 | https://conductscience.org/library/papers/2971656 | PubMed |
| 12 | 6162543 | Assessment of growth-limiting events caused by 5-fluorouracil in mouse cells and in human cells. | Cancer Res | 1980 | https://conductscience.org/library/papers/6162543 | PubMed |
| 13 | 7448754 | Biochemical determinants of responsiveness to 5-fluorouracil and its derivatives in xenografts of human colorectal adenocarcinomas in mice. | Cancer Res | 1981 | https://conductscience.org/library/papers/7448754 | PubMed |
| 14 | 6973389 | Effect of excess folates and deoxyinosine on the activity and site of action of 5-fluorouracil. | Cancer Res | 1981 | https://conductscience.org/library/papers/6973389 | PubMed |
| 15 | 7099147 | Association of cell lethality with incorporation of 5-fluorouracil and 5-fluorouridine into nuclear RNA in human colon carcinoma cells in culture. | Mol Pharmacol | 1982 | https://conductscience.org/library/papers/7099147 | PubMed |
| 16 | 4348213 | Inhibition of ribosomal ribonucleic acid maturation in Novikoff hepatoma cells by 5-fluorouracil and 5-fluorouridine. | J Biol Chem | 1973 | https://conductscience.org/library/papers/4348213 | PubMed |
| 17 | 6173112 | In vivo kinetics of thymidylate synthetase inhibition of 5-fluorouracil-sensitive and -resistant murine colon adenocarcinomas. | Cancer Res | 1982 | https://conductscience.org/library/papers/6173112 | PubMed |
| 18 | 6565175 | Lethality associated with incorporation of 5-fluorouracil into preribosomal RNA. | Mol Pharmacol | 1984 | https://conductscience.org/library/papers/6565175 | PubMed |
| 19 | 6744325 | Thymidylate synthetase inhibition in malignant tumors and normal liver of patients given intravenous 5-fluorouracil. | Cancer Res | 1984 | https://conductscience.org/library/papers/6744325 | PubMed |
| 20 | 498116 | Effect of 5-fluorouracil on RNA metabolism in Novikoff hepatoma cells. | Cancer Res | 1979 | https://conductscience.org/library/papers/498116 | PubMed |
Cited by14
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 40 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 27478804 | Carcinoembryonic Antigen Expression and Resistance to Radiation and 5-Fluorouracil-Induced Apoptosis and Autophagy. | Int J Mol Cell Med | 2016 | https://conductscience.org/library/papers/27478804 | PubMed |
| 14586206 | In vivo antitumor activity of a novel sulfonamide, HMN-214, against human tumor xenografts in mice and the spectrum of cytotoxicity of its active metabolite, HMN-176. | Invest New Drugs | 2003 | https://conductscience.org/library/papers/14586206 | PubMed |
| 12630975 | Population pharmacokinetics and concentration-effect relationships of capecitabine metabolites in colorectal cancer patients. | Br J Clin Pharmacol | 2003 | https://conductscience.org/library/papers/12630975 | PubMed |
| 10804291 | Schedule-dependent interactions between raltitrexed and cisplatin in human carcinoma cell lines in vitro. | Jpn J Cancer Res | 2000 | https://conductscience.org/library/papers/10804291 | PubMed |
| 10359051 | Circumvention of 5-fluorouracil resistance in human stomach cancer cells by uracil phosphoribosyltransferase gene transduction. | Jpn J Cancer Res | 1999 | https://conductscience.org/library/papers/10359051 | PubMed |
| 9811349 | Thymidine phosphorylase activity and prodrug effects in a three-dimensional model of angiogenesis: implications for the treatment of ovarian cancer. | Am J Pathol | 1998 | https://conductscience.org/library/papers/9811349 | PubMed |
| 9792140 | 5-Fluorouracil induces apoptosis in human colon cancer cell lines with modulation of Bcl-2 family proteins. | Br J Cancer | 1998 | https://conductscience.org/library/papers/9792140 | PubMed |
| 9600127 | Increased sensitivity to long-term 5-fluorouracil exposure of human colon cancer HT-29 cells resistant to short-term exposure. | Jpn J Cancer Res | 1998 | https://conductscience.org/library/papers/9600127 | PubMed |
| 8912534 | Pharmacological effects of 5-fluorouracil microspheres on peritoneal carcinomatosis in animals. | Br J Cancer | 1996 | https://conductscience.org/library/papers/8912534 | PubMed |
| 8609072 | Reduced activity of anabolizing enzymes in 5-fluorouracil-resistant human stomach cancer cells. | Jpn J Cancer Res | 1996 | https://conductscience.org/library/papers/8609072 | PubMed |
| 8400672 | A pharmacodynamic and pharmacokinetic study of fluoropyrimidines in a nude mouse system and in postoperative patients with gastric cancer. | Surg Today | 1993 | https://conductscience.org/library/papers/8400672 | PubMed |
| 8144400 | Different modes of cell-killing action between DNA topoisomerase I and II inhibitors revealed by kinetic analysis. | Jpn J Cancer Res | 1994 | https://conductscience.org/library/papers/8144400 | PubMed |
| 1618703 | Kinetic analysis of combination effect of navelbine (KW-2307) with cisplatin against human lung adenocarcinoma PC-12 cells in culture. | Jpn J Cancer Res | 1992 | https://conductscience.org/library/papers/1618703 | PubMed |
| 1506275 | Cell-killing activity and kinetic analysis of a novel antitumor compound NC-190, a benzo[a]phenazine derivative. | Jpn J Cancer Res | 1992 | https://conductscience.org/library/papers/1506275 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2146239
GET https://conductscience.org/api/papers/v1/2146239/references?page=2